Moteur de recherche d’entreprises européennes
Financement de l’UE (5 999 756 €) : Lifecourse biological pathways underlying social differences in healthy ageing Hor01/05/2015 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Lifecourse biological pathways underlying social differences in healthy ageing
"The dramatic differentials in healthy ageing, quality of life and life expectancy between individuals of different socioeconomic groups, is a major societal challenge facing Europe. The overarching aim of the LIFEPATH project is to understand the determinants of diverging ageing pathways among individuals belonging to different socio-economic groups. This will be achieved via an original study design that integrates social science approaches with biology (including molecular epidemiology), using existing population cohorts and omics measurements (particularly epigenomics). The specific objectives of the project are: (a) To show that healthy ageing is an achievable goal for society, as it is already experienced by individuals of high socio-economic status (SES); (b) To improve the understanding of the mechanisms through which healthy ageing pathways diverge by SES, by investigating lifecourse biological pathways using omic technologies; (c) To examine the consequences of the current economic recession on health and the biology of ageing (and the consequent increase in social inequalities); (d) To provide updated, relevant and innovative evidence for healthy ageing policies (particularly “health in all policies”) that address social disparities in ageing and the social determinants of health, using both observational studies as well as an experimental approach based on the existing ""conditional cash transfer"" experiment in New York. To achieve these objectives we will use data from three categories of studies: 1. Europe-wide or national surveys combined with population registry data; 2. Cohorts with intense phenotyping and repeat biological samples (total population >33,000); 3. Large cohorts with biological samples (total population >202,000). The cohorts will provide information on healthy ageing at different stages of life, based on the concepts of life-course epidemiology (""build-up and decline"") and multimorbidity. "
| Cancer Council Victoria | 0,00 € |
| CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS | 0,00 € |
| ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM | 702 813 € |
| HELSINGIN YLIOPISTO | 507 528 € |
| Iigm Foundation | 1 051 500 € |
| Imperial College of Science Technology and Medicine | 936 050 € |
| Institut National de la Sante et de la Recherche Medicale | 232 585 € |
| Instituto de Saude Publica da Universidade do Porto | 210 200 € |
| King's College London | 358 044 € |
| London School of Economics and Political Science | 0,00 € |
| The Provost, Fellows Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin | 330 203 € |
| TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 201 250 € |
| TYOTERVEYSLAITOS | 155 066 € |
| Universita Degli Studi Di Torino | 162 125 € |
| Universite Paul Sabatier Toulouse III | 351 500 € |
| University College London | 474 831 € |
| Zadig Srl | 326 063 € |
https://cordis.europa.eu/project/id/633666
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.